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that the trend in use of insulin in the Czech republic
should be interpreted positively. Similarly, the decrease of
sulfonylurea use and the increase of that of metformin
are good news. New drugs may offer better treatment op-
tions, however, their actual value should be properly as-
sessed in clinical practice.
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OBJECTIVES: Recent population studies and meta-anal-
yses indicate that increased post-prandial blood glucose
(PPG) level is an independent risk factor for coronary
heart disease (CHD), stroke, cardiovascular disease (CVD)
death. A modeling study was performed to combine best
available data with costs of complications to project pos-
sible long-term clinical and cost outcomes for patients
with different baseline PPG levels.
METHODS: Risks of CHD, stroke, and CVD death de-
rived from Framingham formulae were combined with
PPG-dependent hazard ratios for incident CHD, stroke,
and CVD death to calculate life expectancy dependent on
baseline PPG. Direct costs of cardiovascular complica-
tions were projected over patients’ lifetime using a Markov
simulation model. Costs of treating cardiovascular com-
plications were retrieved from published sources. A French,
third-party-payer cost perspective was taken, and only di-
rect costs were included in the analysis. Costs were dis-
counted at an annual rate of 5%.
RESULTS: A typical population of type 2 diabetes pa-
tients aged 60.1 years with PPG levels of 15.3, 14.7, or
13.8 mmol/l at baseline was calculated to have life ex-
pectancies of 18.9, 19.4, and 19.9 years respectively.
Lifetime costs per patient (discounted at 5% per annum)
due to CVD complications were calculated to be FF
58,793, FF 57,912, and FF 56,565 respectively.
CONCLUSIONS: Patients with lower PPG levels are
likely to have improved life expectancy and reduced costs
due to cardiovascular complications. It is possible that
newer interventions that improve PPG levels will be cost-
effective, as the costs of interventions will be offset by re-
duced costs due to cardiovascular complications.
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OBJECTIVES: While the patient-reported effects of hy-
poglycemia have been investigated, little has been done
with hyperglycemia. This research was designed to en-
hance our understanding in this area.
METHODS: Using hand-held computers we assessed the
acute and cumulative effects of hyperglycemia on mood
and cognitive functioning. The sample consisted of 105
adults with type 1 diabetes mellitus who entered their de-
gree of symptoms (tired/sleepy, dry eyes/nose/mouth,
sweet taste, need to urinate), cognitive functioning (sub-
tractions, verbal fluency and choice-reaction time tests)
and their blood glucose (BG) over four weeks. In addi-
tion, they completed several psychometric instruments,
including the Diabetes Quality of Life scale.
RESULTS: All four symptoms steadily increased as BG
rose in the following increments: 110-144mg/dl; 145-180
mg/dl; 181-220 mg/dl; 220-270 mg/dl; 270mg/dl (p 
.001). Only verbal fluency and mental arithmetic perfor-
mance worsened with hyperglycemia (BGs  270, p 
.005). Individuals with more frequent BGs  160mg/dl
reported more worry about hyperglycemia, poorer qual-
ity of life and more hassles around symptoms and com-
plications, while being less likely to perform non-routine
tasks to avoid hyperglycemia.
CONCLUSIONS: Both between- and within-subject anal-
yses of acute and cumulative effects demonstrated hyper-
glycemia has psychological consequences in type 1 diabetes
mellitus and may result in less motivation to change rou-
tine behaviors to reduce the frequency of hyperglycemia.
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OBJECTIVE: To evaluate the validity and reliability of
the English version of KINDL (a self-administered ge-
neric quality of life instrument originally developed in
German) in Singaporean children with diabetes.
METHODS: Consecutive patients with diabetes (both
types I and II) attending the endocrinology clinic at Kan-
dang Kerbau Women and Children’s Hospital were asked
to fill in the KINDL questionnaire. Healthy controls were
recruited via street interview conducted outside commu-
nity libraries located in different parts of the island.
RESULTS: Thirty-five diabetics (mean age: 14.5  1.48
yrs, 17 males and 18 females) and 34 healthy controls
(mean age: 14.5  1.05 yrs, 17 males and 17 females)
completed the questionnaire. The overall result showed
that diabetic patients have a significantly higher overall
score compared to the controls (patient vs. control: 57.0 
8.7 vs. 48.8  8.8*, p  .01). Item reduction of individ-
ual domains did not change the overall pattern or the dif-
ference in magnitude between scores obtained by the two
groups. However, there were improvements (in the vicinity
of four to five percent) in overall scores when either the
